What must mental health professionals understand as psychedelic therapies move from controlled research environments toward wider clinical practice?
The New Science of Psychedelic Medicine offers a comprehensive, evidence-focused examination of the compounds, mechanisms, protocols, and professional responsibilities shaping this rapidly developing field. Written as a clinical reference, it helps psychiatrists, psychologists, therapists, researchers, trainees, and other healthcare professionals navigate the science without losing sight of safety, ethics, or the limitations of the evidence.
Across twenty detailed chapters, readers will explore:
Balancing therapeutic promise with scientific caution, this reference distinguishes established findings from preliminary evidence and emerging hypotheses. Practical appendices provide concise guidance on screening and outcome instruments, drug interactions, regulatory considerations, and professional training resources.
Develop a rigorous, clinically grounded understanding of psychedelic medicine—and prepare to evaluate its evolving role in responsible mental healthcare.
"synopsis" may belong to another edition of this title.
Seller: California Books, Miami, FL, U.S.A.
Condition: New. Print on Demand. Seller Inventory # I-9798172458729
Seller: PBShop.store UK, Fairford, GLOS, United Kingdom
PAP. Condition: New. New Book. Shipped from UK. Established seller since 2000. Seller Inventory # L2-9798172458729
Quantity: Over 20 available
Seller: AHA-BUCH GmbH, Einbeck, Germany
Taschenbuch. Condition: Neu. Neuware - What must mental health professionals understand as psychedelic therapies move from controlled research environments toward wider clinical practice The New Science of Psychedelic Medicine offers a comprehensive, evidence-focused examination of the compounds, mechanisms, protocols, and professional responsibilities shaping this rapidly developing field. Written as a clinical reference, it helps psychiatrists, psychologists, therapists, researchers, trainees, and other healthcare professionals navigate the science without losing sight of safety, ethics, or the limitations of the evidence.Across twenty detailed chapters, readers will explore: - The receptor pharmacology and neurobiological effects of psilocybin, MDMA, ketamine, esketamine, and related compounds- Neuroimaging, neuroplasticity, altered states of consciousness, and their potential therapeutic significance- Clinical research involving treatment-resistant depression, PTSD, end-of-life distress, substance dependence, OCD, eating disorders, and chronic pain- Patient selection, psychiatric screening, contraindications, and drug-interaction considerations- Preparation, dosing-session design, integration, adverse-event management, and crisis protocols- Therapist competency, ethical safeguards, regulatory frameworks, and clinical program implementation- Next-generation compounds, biomarkers, precision psychiatry, and future research directionsBalancing therapeutic promise with scientific caution, this reference distinguishes established findings from preliminary evidence and emerging hypotheses. Practical appendices provide concise guidance on screening and outcome instruments, drug interactions, regulatory considerations, and professional training resources.Develop a rigorous, clinically grounded understanding of psychedelic medicine-and prepare to evaluate its evolving role in responsible mental healthcare. Seller Inventory # 9798172458729